コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 bundantly present in both the peritoneum and retroperitoneum.
2 internal calcific densities was noted in the retroperitoneum.
3 al layers separated mesocolon and underlying retroperitoneum.
4 ended caudally surrounding the ureter in the retroperitoneum.
5 rysm with haematoma spreading into the right retroperitoneum.
6 apancreatic sites are bile duct, kidney, and retroperitoneum.
7 rbor either viable cancer or teratoma in the retroperitoneum.
8 to 13 years), including two patients in the retroperitoneum.
9 operitoneum is critical to prevent LR in the retroperitoneum.
10 and were found to have only teratoma in the retroperitoneum.
11 parates the perirenal space from the central retroperitoneum.
12 nvolving the perirenal spaces or the central retroperitoneum.
13 aphy-guided GFN blocks were performed in the retroperitoneum.
19 n of residual postchemotherapy masses in the retroperitoneum and chest, including three who also had
21 often located in the deep soft tissue of the retroperitoneum and intra-abdominal pelvic region or in
22 especially those with disease limited to the retroperitoneum and normal markers, as an option to avoi
23 onstrated a substantial amount of gas in the retroperitoneum and peritoneal cavity, which raised a su
24 infection both to the peritoneal cavity and retroperitoneum and result in a substantial amount of ga
26 drenal myelolipomas, found most often in the retroperitoneum); and (d) myelolipomatous foci within ot
27 the aneurysm wall, fibrosis of the adjacent retroperitoneum, and rigid adherence of the adjacent str
28 emonstrate that the contiguous mesocolon and retroperitoneum are separated by mesothelial and connect
30 llections in the mediastinum, chest wall, or retroperitoneum; (b) malignancies that were detected, st
31 One prominent cluster (n = 37; 36 testis retroperitoneum), consisting of 26 (70%) good-risk (GR),
32 e located in the liver, lung, adrenal gland, retroperitoneum, gluteal muscle, inguinal mass, and subc
33 the pelvis in 42% of patients (110), in the retroperitoneum in 17% (45), and in a supradiaphragmatic
34 elvis in 40.6% of patients (n = 102), in the retroperitoneum in 19.5% of patients (n = 49), and in su
35 were mainly observed at the following sites: retroperitoneum in 5/8 patients (62.5%), cardiovascular
36 Overall, 56 patients (75%) had LR in the retroperitoneum, including 25 (93%) of 27 patients initi
38 data suggest that meticulous control of the retroperitoneum is critical to prevent LR in the retrope
41 ues (ie, Radiofrequency, Thermal, Chemical), Retroperitoneum, Microwave Ablation, Hydrodissection (C)
44 patients (4%) experienced recurrence in the retroperitoneum, of whom two patients died of disease.
45 ease from the perirenal space to the central retroperitoneum or from the central retroperitoneum to t
46 ned as recurrence in the original tumor bed, retroperitoneum, or within the abdominal cavity or pelvi
47 an extremity in 34, the head/neck in 23, the retroperitoneum/pelvis in 21, and other sites in 11.
48 oscopic appearance of mesocolon, fascia, and retroperitoneum, prior to and after colonic mobilization
49 responsive to mechanical brushing within the retroperitoneum, the snare is likely to change serotoner
53 However, no leakage from the ureter to the retroperitoneum was observed, proving that the changes d
54 liac arteries, and spreads into the adjacent retroperitoneum, where it frequently causes ureteral obs
55 y, pcRPLND provides effective control of the retroperitoneum with few relapses and GCT-related deaths